Engaging Community-Based Cancer Physicians: Experience of the Memorial Sloan Kettering Cancer Center Cancer Alliance.


Journal

Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515

Informations de publication

Date de publication:
01 09 2019
Historique:
received: 05 11 2018
accepted: 08 03 2019
entrez: 6 9 2019
pubmed: 6 9 2019
medline: 18 8 2020
Statut: ppublish

Résumé

The proliferation of relationships between community health systems and academic medical centers has created a need to identify effective components of these models. This article reports on frontline physician experiences, with one such relationship established through the Memorial Sloan Kettering Cancer Center (MSK) Cancer Alliance. MSK created the Alliance with the goals of rapidly bringing the newest standards of care into community settings and increasing patient access to clinical trials in their local communities. Alliance leadership administered a 10-question anonymous survey to physicians treating patients with cancer across the 3 Alliance member health systems: Hartford HealthCare Cancer Institute, Lehigh Valley Cancer Institute, and Miami Cancer Institute at Baptist Health South Florida. The purpose of the survey was to identify opportunities to improve physician engagement. There were 103 clinician respondents across Alliance members, of which 87 reported participation in a disease management team and were included in the final analysis. Most respondents reported high value from Alliance activities, such as attending MSK tumor boards (94%) and lecture series (96%), among those who reported them applicable. Across all respondents, most reported satisfaction with engagement opportunities, such as MSK physician participation in their institution's meetings (76%). When asked where they would like to see increased engagement, the most commonly reported response was for more lecture series (45%). Most respondents (88%) reported that the Alliance led to practice change, either for themselves or for other clinicians at their institution. Many attributed this practice change to MSK disease-specific process measures. The activities most valued by community physicians were heavily physician relationship-based. The encouraging experience of the MSK Cancer Alliance suggests that activities involving physician investment may be effective for promoting practice change in the context of cross-institution relationships. Future research is needed in this area.

Sections du résumé

BACKGROUND
The proliferation of relationships between community health systems and academic medical centers has created a need to identify effective components of these models. This article reports on frontline physician experiences, with one such relationship established through the Memorial Sloan Kettering Cancer Center (MSK) Cancer Alliance. MSK created the Alliance with the goals of rapidly bringing the newest standards of care into community settings and increasing patient access to clinical trials in their local communities.
METHODS
Alliance leadership administered a 10-question anonymous survey to physicians treating patients with cancer across the 3 Alliance member health systems: Hartford HealthCare Cancer Institute, Lehigh Valley Cancer Institute, and Miami Cancer Institute at Baptist Health South Florida. The purpose of the survey was to identify opportunities to improve physician engagement.
RESULTS
There were 103 clinician respondents across Alliance members, of which 87 reported participation in a disease management team and were included in the final analysis. Most respondents reported high value from Alliance activities, such as attending MSK tumor boards (94%) and lecture series (96%), among those who reported them applicable. Across all respondents, most reported satisfaction with engagement opportunities, such as MSK physician participation in their institution's meetings (76%). When asked where they would like to see increased engagement, the most commonly reported response was for more lecture series (45%). Most respondents (88%) reported that the Alliance led to practice change, either for themselves or for other clinicians at their institution. Many attributed this practice change to MSK disease-specific process measures.
CONCLUSIONS
The activities most valued by community physicians were heavily physician relationship-based. The encouraging experience of the MSK Cancer Alliance suggests that activities involving physician investment may be effective for promoting practice change in the context of cross-institution relationships. Future research is needed in this area.

Identifiants

pubmed: 31487684
doi: 10.6004/jnccn.2019.7295
pii: jnccn18324
pmc: PMC7513935
mid: NIHMS1614821
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1083-1087

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Références

N Engl J Med. 2014 Jan 16;370(3):198-9
pubmed: 24328443
JAMA Oncol. 2015 Dec;1(9):1303-10
pubmed: 26448610
JAMA. 2013 Nov 13;310(18):1964-70
pubmed: 24219952
JAMA. 1998 Nov 25;280(20):1747-51
pubmed: 9842949
Acad Med. 2005 Mar;80(3):253-60
pubmed: 15734807
J Natl Compr Canc Netw. 2007 Oct;5(9):875-82
pubmed: 17977500
J Natl Cancer Inst. 2014 Sep 01;106(8):dju166
pubmed: 25178694
Acad Med. 1995 Jan;70(1):21-6
pubmed: 7826437
J Oncol Pract. 2018 Dec;14(12):e823-e833
pubmed: 30537462
J Oncol Pract. 2016 Jan;12(1):67-8, e44-51
pubmed: 26265173

Auteurs

Allison Lipitz-Snyderman (A)

Center for Health Policy and Outcomes.

Jessica Kennington (J)

Department of Strategic Partnerships, and.

Brooke Hogan (B)

Department of Strategic Partnerships, and.

Deborah Korenstein (D)

Center for Health Policy and Outcomes.
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Leonard Kalman (L)

Miami Cancer Institute, Miami, Florida.

Suresh Nair (S)

Lehigh Valley Cancer Institute, Allentown, Pennsylvania; and.

Peter Yu (P)

Hartford HealthCare Cancer Institute, New Britain, Connecticut.

Paul Sabbatini (P)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

David Pfister (D)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH